Introducing Retrosynthesis in GOSTAR™ Small Molecules: Bridging SAR and Synthesis Planning Medicinal chemistry is an iterative process of designing, synthesizing, and evaluating compounds to optimize potency,…Vinayak ManeJuly 14, 2026 Read More
When LLMs Meet Real Chemistry Data: Where the Cracks Show Excelra combines structured biological curation, multi-source PTM data integration, and domain expertise to help drug…Vinayak ManeJune 2, 2026 Read More
Expanding GOSTAR™ Small Molecules with 1 Million+ New SAR Data Points to Support Data-Driven Drug Design and Optimization Between March and November 2025, GOSTAR Small Molecules continued steady, high-quality growth across compounds, SAR,…Vinayak ManeDecember 9, 2025 Read More
Expanding GOSTARᵀᴹ TPD with 10K+ New Degraders for Smarter Drug Design and Strategic Decisions Between April and July 2025, the GOSTARᵀᴹ TPD database added 20% more content. More than…Vinayak ManeAugust 11, 2025 Read More
Excelra and AsedaSciences® announce a strategic Co-Marketing Agreement to provide scientists with single, easy-to-use platform, for small molecule toxicity assessment Schindellegi, Switzerland, June 2024 – Small molecule toxicity assessment remains a hurdle in drug development,…Prashant SharmaApril 7, 2025 Read More
GOSTAR™ SAR Database: Now Faster, Smarter, and More Efficient The GOSTAR™ SAR database has always been the gold standard for medicinal chemists and drug…Prashant SharmaApril 7, 2025 Read More
Orogen Therapeutics Partners with Excelra for GOSTAR® Partnership Strengthens Orogen Therapeutics’ AI-Driven Drug Discovery Platform HYDERABAD, India / WOBURN, Mass (Dec 13,…Prashant SharmaDecember 13, 2024 Read More